Showing results (371-380 of 387) with videos related to
Sort By:
Pageof 39
Frontiers in Veterinary Science|December 28, 2020
Licochalcone a Exhibits Leishmanicidal Activity <i>in vitro</i> and in Experimental Model of <i>Leishmania</i> (<i>Leishmania</i>) <i>Infantum</i>Julia M Souza, Érica A A de Carvalho, Ana Carolina B B Candido, et al.Bioorganic & Medicinal Chemistry|February 18, 2014
1,2,3-triazole-, arylamino- and thio-substituted 1,4-naphthoquinones: potent antitumor activity, electrochemical aspects, and bioisosteric replacement of C-ring-modified lapachonesEduardo H G da Cruz, Caio M B Hussene, Gleiston G Dias, et al.ACS Pharmacology & Translational Science|December 20, 2021
High-Throughput Screening Reveals New Glutaminase Inhibitor MoleculesRenna K E Costa, Camila T Rodrigues, Jean C H Campos, et al.Acta Tropica|August 2, 2025
Polymeric micelles loaded with a 1,2,3-triazolium derivative: a promising strategy against tegumentary leishmaniasisCamila S Freitas, Daniela P Lage, Breno L Pimenta, et al.Pathogens (Basel, Switzerland)|December 31, 2025
Immunotherapeutics Combining a Recombinant Chimeric Protein, Monophosphoryl Lipid A, and Miltefosine Against Visceral LeishmaniasisMarcelo M Jesus, Daniela P Lage, Breno L Pimenta, et al.Viruses|February 26, 2022
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant CellsCarolina Q Sacramento, Natalia Fintelman-Rodrigues, Suelen S G Dias, et al.Experimental Parasitology|June 25, 2025
Urine- and serum-based ELISA using a new recombinant chimeric protein to diagnose tegumentary and visceral leishmaniasis: a preliminary studyRaquel S B Câmara, Ana L Silva, Camila S Freitas, et al.Parasitology|November 28, 2024
Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasisDaniela P Lage, Danniele L Vale, Fabiana A G Maia, et al.Cellular Immunology|April 8, 2025
A new chimeric protein composed by T-cell epitopes from peroxidoxin and pyridoxal kinase proteins is protective against visceral leishmaniasisDaniela P Lage, Danniele L Vale, Marcela G P Silva, et al.Frontiers in Immunology|March 7, 2022
Simvastatin Downregulates the SARS-CoV-2-Induced Inflammatory Response and Impairs Viral Infection Through Disruption of Lipid RaftsLívia Teixeira, Jairo R Temerozo, Filipe S Pereira-Dutra, et al.Pageof 39